Parameters Associated with v-HLNs in BC Cohort (145 Patients) on Univariate and Multivariate Logistic Regression Analyses
| v-HLNs | ||||
|---|---|---|---|---|
| Univariate | Multivariate | |||
| Variable | P | OR | P | OR |
| Age | ||||
| ≥50 y | 0.17 | 1 (reference) | — | — |
| <50 y | 1.9 (0.7–4.9) | — | ||
| Immunosuppression | ||||
| Yes | 0.26 | 1 (reference) | — | — |
| No | 1.2 (0.9–1.9) | — | ||
| Lymphopenia | ||||
| Yes | 1 (reference) | 1 (reference) | ||
| No | 0.04 | 2.5 (1.1–6.1) | 0.02 | 2.9 (1.2–7.4) |
| Unknown | 0.19 | 1.9 (0.8–6.7) | 0.16 | 2.0 (0.8–6.9) |
| Type of vaccine | ||||
| mRNA | 0.90 | 1 (reference) | — | — |
| Viral vector | 0.9 (0.3–2.7) | — | ||
| Number of vaccine doses | ||||
| 1 | 0.55 | 1 (reference) | — | — |
| 2 | 0.8 (0.4–1.6) | — | ||
| Interval* | ||||
| ≥30 d | 0.12 | 1 (reference) | 0.06 | 1 (reference) |
| <30 d | 2.0 (0.9–4.8) | 2.3 (0.9–6.3) | ||
* Between last injection and PET.
Data in parentheses are 95% CIs.